ATMP Manufacturing: Complex Challenges Require Complex Solutions
Demand for ATMPs could outstrip supply by tenfold within the next three years unless companies find ways to scale up production.
Experts working in the advanced therapy sector tell In Vivo how novel solutions can empower cell and gene therapy manufacturers to reduce costs, improve scalability and optimize their processes – improving the clinical profile and commercial viability of products.
